Provided by Tiger Trade Technology Pte. Ltd.

Atai Beckley Inc

4.03
+0.02000.50%
Post-market: 4.040.0100+0.25%19:57 EDT
Volume:3.86M
Turnover:15.46M
Market Cap:1.48B
PE:-1.38
High:4.08
Open:4.03
Low:3.95
Close:4.01
52wk High:6.75
52wk Low:1.38
Shares:367.00M
Float Shares:309.00M
Volume Ratio:0.87
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9137
EPS(LYR):-2.9137
ROE:-389.98%
ROA:-30.75%
PB:6.67
PE(LYR):-1.38

Loading ...

AtaiBeckley Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
May 09

Atai Beckley N.V. (ATAI) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Apr 29

AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research

GlobeNewswire
·
Apr 27

FDA Fast-Tracks Review of Some Psychedelic Drugs. This Stock Is Set to Benefit. -- Barrons.com

Dow Jones
·
Apr 25

Psychedelic Pharma Stocks Are Riding High. Past Cannabis Returns Are a Reality Check. -- Barrons.com

Dow Jones
·
Apr 24

Atai Beckley publishes 2025 annual report

Reuters
·
Apr 23

Atai Beckley CMO Craig Kevin James disposes 42,579 shares worth $212,895

Reuters
·
Apr 23

Atai Beckley announces annual shareholder meeting via webcast

Reuters
·
Apr 23

Analysts Offer Insights on Healthcare Companies: Atai Beckley N.V. (ATAI) and Greenwich LifeSciences (GLSI)

TIPRANKS
·
Apr 22

Ataibeckley Announces Additional Phase 2a Results for Emp-01 (Oral R-Mdma) Showing Large and Consistent Improvements in Social Anxiety Disorder

THOMSON REUTERS
·
Apr 22

Ataibeckley Inc: Emp‑01 Was Generally Safe and Well Tolerated, No Severe or Serious Adverse Events

THOMSON REUTERS
·
Apr 22

Ataibeckley Inc: Emp-01 Demonstrated Large, Clinically Meaningful Reduction in Patient-Reported Sad Symptoms at Day 43

THOMSON REUTERS
·
Apr 22

EXPLAINER-What to know about psychedelic therapies cited by Trump

Reuters
·
Apr 22

Psychedelic Stocks Surge After Trump Supports Using Drugs Like LSD for Mental Health

Dow Jones
·
Apr 21

NASD Most Active Issues

Dow Jones
·
Apr 21

H.C. Wainwright Reaffirms Their Buy Rating on Atai Beckley N.V. (ATAI)

TIPRANKS
·
Apr 21

BUZZ-U.S. STOCKS ON THE MOVE-Adobe, Agios, QXO

Reuters
·
Apr 20

AtaiBeckley Up Over 28%, On Pace For Record Percent Increase -- Data Talk

Dow Jones
·
Apr 20

Psychedelic Drug Stocks Surge with Compass Pathways up 37%; Atai Beckley up 28%. Trump Accelerates Psychedelic Research With $50 Million Ibogaine Commitment

Benzinga
·
Apr 20

ATAI Life Sciences Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Apr 20